Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effectiveness of ovarian suspension in preventing post operative ovarian adhesions in women with pelvic endometriosis
ISRCTN ISRCTN24242218
ClinicalTrials.gov identifier
Public title Effectiveness of ovarian suspension in preventing post operative ovarian adhesions in women with pelvic endometriosis
Scientific title Effectiveness of ovarian suspension in preventing post operative ovarian adhesions in women with pelvic endometriosis: A randomised controlled trial
Acronym N/A
Serial number at source N0263139724
Study hypothesis Added 03/11/10:
Suspending the ovaries to the anterior abdominal wall (ovarian suspension) after laparoscopic surgery for severe pelvic endometriosis for 36 to 48 hours will reduce the incidence of post operative ovarian adhesion.

No information provided at time of registration.

Please note that as of 03/11/10 this record has been extensively updated, with further revisions and clarifications to the record on 12/11/10. Due to issues with recruitment the trial, originally planned for 19/11/03 to 01/11/08, was stopped and underwent protocol and ethics amendments. Details of these amendments can be found in the relevant field with one of the above update dates.
Lay summary
Ethics approval Added 12/11/10: The Medical Ethical Committees of the University College Hospital, London approved ammendments to the protocol on the 8th of April 2009 and the 29th of April 2010 (ref: 03/0279).

Details of the original ethics approval were not provided at the time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Endometriosis; Laparoscopic surgery
Participants - inclusion criteria Added 03/11/10:
1. Age 19 or older
2. Internal scan not contraindicated
3. Severe pelvic endometriosis involving rectovaginal space and/or both ovaries
4. Fertility preserving surgery

Information not provided at time of registration
Participants - exclusion criteria Added 03/11/10:
1. Mild or moderate endometriosis
2. Incomplete resection of pelvic endometriosis (cyst drainage pre-IVF treatment or planned two stage operations)
3. Patients undergoing radical surgery for endometriosis including oophrectomies or hysterectomies
4. Complications requiring ileostomies or open surgery

Information not provided at time of registration
Anticipated start date 01/10/2008
Anticipated end date 01/06/2011
Status of trial Completed
Patient information material Not available in web format, please use contact details below to request a patient information sheet
Target number of participants Added 03/11/10: 50 patients (at time of registration: 20 patients)
Interventions Current information as of 12/11/10:
Ovarian suspension following laparoscopic excision of severe pelvic endometriosis:
Patients will be randomised at the time of surgery to have either their left or right ovary suspended. The other ovary will be allowed to fall back into the pelvis, therefore acting as a control within the same patient.
Ovarian suspension will be for at least 36 hours. An extra 12 hours is allowed for practical reasons in situations where sutures may needs to be removed in the middle of the night. There will be no comparision between variations in the duration of suspension.

Initial information at time of registration:
1. Ovary suspension
2. Non ovary suspension
Primary outcome measure(s) Current information as of 03/11/10:
Presence of ovarian adhesions as assessed by pelvic ultrasound scan, 3 months post-operatively.

Initial information at time of registration:
The grade of peri-ovarian adhesion with and without ovarian suspension.
Secondary outcome measure(s) Current information as of 03/11/10:
Presence, intensity and site of postoperative pain

Initial information at time of registration:
Difference in pain between the 2 sides of the abdomen in the first three post-op days.
Sources of funding University College London Hospitals NHS Trust (UK)
Trial website
Publications
Contact name Dr  William  Hoo
  Address Clinic 3
Gynaecology Diagnostic Ultrasound Unit
Elizabeth Garrett Anderson Wing
University College London Hospital
235 Euston Road
  City/town London
  Zip/Postcode NW1 2BU
  Country United Kingdom
  Tel +44 (0)20 7380 9411
  Fax +44 (0)20 7691 5861
  Email
Sponsor Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
  Address The Department of Health,
Richmond House,
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2004
Last edited 12/11/2010
Date ISRCTN assigned 30/09/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central